An Exclusive Look at Sixty Degrees Pharma (Nasdaq: SXTP) with CEO Geoff Dow

Jul. 12, 2023
Learn about Sixty Degrees Pharma (Nasdaq: SXTP) from CEO Geoff Dow. In this exclusive overview, Dow provides insight into the company's mission to develop and commercialize new therapies for a range of infectious diseases, including its FDA-approved malaria preventative treatment ARAKODA® and the Company's current pipeline development programs for Tafenoquine and Celgosivir targeting COVID-19, fungal, tick-borne, and other viral diseases. Learn more about this game-changing small-cap stock by visiting SXTPinfo.com today.

 Read More


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market